Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Sindall Group Regulatory News (MGNS)

Share Price Information for Morgan Sindall Group (MGNS)

Share Price is delayed by 15 minutes
Get Live Data
4,430.00    0.00 (0.00%)
Bid:
4,424.00
Ask:
4,430.00
Spread: 6.00 (0.136%)
Market Cap: £2.07b
MGNS Live PriceLast checked at - London Stock Exchange

Intraday Morgan Sindall Group Share Chart

Director/PDMR Shareholding

9 Mar 2010 17:14

RNS Number : 3297I
Morgan Sindall PLC
09 March 2010
 



 Morgan Sindall plc

 

 ('the Company')

 

Notification of Transactions by Directors

 

 

Executive Remuneration Plan 2005 (the 'Plan')

 

On 6 March 2007 the Company granted awards under the Plan to its executive directors in respect of ordinary shares of 5p each in the Company ('shares'). These awards took the form of performance shares or, at the election of each individual, options to subscribe for shares and were subject to performance conditions based on a growth in adjusted earnings per share over the three years ended 31 December 2009. Following completion of the performance period, the Company announces that 25% of the performance share awards have vested and none of the share options have become exercisable. That part of the awards which has not vested or become exercisable has now lapsed.

 

The Company therefore announces, in accordance with the Company's obligations under paragraph 3.1.4 R (1) of the Disclosure and Transparency Rules, the numbers of shares which were transferred to the individuals below on 8 March 2010. These shares comprised 25% of those performance shares awarded to the individuals on 6 March 2007 and additional shares representing the dividend equivalent to which the individuals are entitled under the Plan.

 

These shares were satisfied from market purchased shares held in the Morgan Sindall Employee Benefit Trust.

 

In addition, certain of the directors named below have disposed of a proportion of the shares vesting in order to fund the tax and national insurance contribution payable in respect of them.

 

Name of Director

Number of performance shares awarded

6 March 2010

 

 

25% of performance share awards vesting

Number of dividend equivalent shares

Total number of shares vested

Number of shares disposed

 

 

 

Number of performance share awards lapsed

 

 

 

Number of share

options lapsed

Paul Smith

13,889

3,472

694

4,166

Nil

10,417

55,556

David Mulligan

6,790

1,697

339

2,036

Nil

5,093

27,160

Paul Whitmore

14,198

3,549

709

4,258

1,746

10,649

-

John Morgan

-

-

-

-

-

-

94,444

 

 

The market value of a share on 5 March 2010 was 555.205p and the shares disposed were sold to the Morgan Sindall Employee Benefit Trust at that price.

 

Following these transactions, the interests (all of which are beneficial) of the above directors in the share capital of the Company are as follows:

 

Name of Director

Beneficial interest in shares

% issued share capital of the Company

Total number of shares over which options are held

Total number of conditional share awards held

Paul Smith

217,915

0.50

319,488

50,374

David Mulligan

24,544

0.06

180,426

28,818

Paul Whitmore

62,840

0.15

1,338

52,960

John Morgan

4,497,508

10.42

531,296

0

 

 

Enquiries:

Mary Nettleship Tel: 020 7307 9200

Company Secretary

 

9 March 2010

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSLLFLDVVIAIII
Date   Source Headline
3rd Jun 202611:56 amRNSDirector/PDMR Shareholding
1st Jun 20269:27 amRNSTotal Voting Rights
27th May 20261:29 pmRNSAdmission to Trading
20th May 202611:35 amRNSIssue of Equity
7th May 202612:38 pmRNSResult of AGM
1st May 20261:33 pmRNSDirector/PDMR Shareholding
1st May 202610:57 amRNSTotal Voting Rights
20th Apr 20263:44 pmRNSHolding(s) in Company
16th Apr 20264:09 pmRNSHolding(s) in Company
16th Apr 20267:00 amRNSTrading and Outlook for 2026
14th Apr 20262:18 pmRNSAdmission to Trading
1st Apr 20269:53 amRNSTotal Voting Rights
26th Mar 20261:27 pmRNSHolding(s) in Company
24th Mar 202612:56 pmRNSAnnual Financial Report
20th Mar 202612:42 pmRNSIssue of Equity
9th Mar 20263:35 pmRNSDirector/PDMR Shareholding
9th Mar 20263:35 pmRNSDirector/PDMR Shareholding
9th Mar 20263:30 pmRNSDirector/PDMR Shareholding
9th Mar 20263:30 pmRNSDirector/PDMR Shareholding
4th Mar 20262:38 pmRNSDirector/PDMR Shareholding
4th Mar 20262:36 pmRNSDirector/PDMR Shareholding
3rd Mar 20263:33 pmRNSIssue of Equity / Admission to Trading
2nd Mar 20269:22 amRNSTotal Voting Rights
26th Feb 20269:53 amRNSDirector Declaration
25th Feb 20267:00 amRNSResults for the Full Year ended 31 December 2025
12th Feb 20267:00 amRNSTrading and Outlook for 2026
2nd Feb 20269:13 amRNSTotal Voting Rights
19th Jan 20267:00 amRNSNotice of Full Year Results
2nd Jan 202611:09 amRNSTotal Voting Rights
16th Dec 202510:16 amRNSAdditional Listing
2nd Dec 20259:12 amRNSTotal Voting Rights
25th Nov 20254:14 pmRNSHolding(s) in Company
12th Nov 20254:07 pmRNSDirector/PDMR Shareholding
3rd Nov 202510:58 amRNSTotal Voting Rights
20th Oct 202511:24 amRNSBlock listing Interim Review
20th Oct 20259:32 amRNSDirector/PDMR Shareholding
2nd Oct 20257:00 amRNSTrading Update and Outlook for 2025
1st Oct 20259:05 amRNSTotal Voting Rights
1st Sep 20258:59 amRNSTotal Voting Rights
4th Aug 20253:09 pmRNSDirector/PDMR Shareholding
1st Aug 20257:00 amRNSTotal Voting Rights
29th Jul 20257:00 amRNSResults For the Half Year (HY) Ended 30 June 2025
18th Jul 20258:40 amRNSHolding(s) in Company
1st Jul 20259:34 amRNSTotal Voting Rights
25th Jun 20258:47 amRNSAdditional Listing
24th Jun 20257:00 amRNSNotice of Half Year Results
17th Jun 20257:00 amRNSTrading Update and Outlook for 2025
16th Jun 20251:55 pmRNSDirector/PDMR Shareholding
2nd Jun 20253:45 pmRNSTotal Voting Rights
2nd Jun 202511:14 amRNSCompany Secretary Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.